DermTech to Slash 56% of Workforce, Explore Options

Dow Jones04-19

By Ben Glickman

DermTech said Thursday that it plans to cut more than half of its workforce as it explores strategic alternatives, its third round of layoffs in less than a year.

The San Diego-based dermatology-treatment company said that it would cut about 100 employees, or about 56% of its workforce, as it looks to conserve cash.

DermTech's board has engaged TD Cowen to explore strategic alternatives, including a possible sale or merger.

The company said it expects to incur a restructuring charge of about $1.6 million in the second quarter connected to the layoffs.

DermTech said it plans to continue laboratory operations during the strategic review, believes it can still process orders of its melanoma test.

The company said in late January that it would cut 15% of its headcount, or 30 employees, in a bid to prioritize revenue growth and cut expenses. Those reductions were on top of plans to cut 15% of its headcount in June as the company suspended all of its pipeline programs.

DermTech suspended its pipeline programs in June and looked to focus on growth potential for its melanoma test.

Write to Ben Glickman at ben.glickman@wsj.com

(END) Dow Jones Newswires

April 18, 2024 16:37 ET (20:37 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2428420675?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-04-19 04:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2428420675","market":"nz","top_or_hot":-1,"title":"DermTech to Slash 56% of Workforce, Explore Options","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Ben Glickman \n</p>\n<pre>\n \n</pre>\n<p>\n  DermTech said Thursday that it plans to cut more than half of its workforce as it explores strategic alternatives, its third round of layoffs in less than a year. \n</p>\n<p>\n  The San Diego-based dermatology-treatment company said that it would cut about 100 employees, or about 56% of its workforce, as it looks to conserve cash. \n</p>\n<p>\n  DermTech's board has engaged TD Cowen to explore strategic alternatives, including a possible sale or merger. \n</p>\n<p>\n  The company said it expects to incur a restructuring charge of about $1.6 million in the second quarter connected to the layoffs. \n</p>\n<p>\n  DermTech said it plans to continue laboratory operations during the strategic review, believes it can still process orders of its melanoma test. \n</p>\n<p>\n  The company said in late January that it would cut 15% of its headcount, or 30 employees, in a bid to prioritize revenue growth and cut expenses. Those reductions were on top of plans to cut 15% of its headcount in June as the company suspended all of its pipeline programs. \n</p>\n<p>\n  DermTech suspended its pipeline programs in June and looked to focus on growth potential for its melanoma test. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Ben Glickman at ben.glickman@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 18, 2024 16:37 ET (20:37 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DermTech to Slash 56% of Workforce, Explore Options</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDermTech to Slash 56% of Workforce, Explore Options\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-19 04:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Ben Glickman \n\n\n \n\n\n  DermTech said Thursday that it plans to cut more than half of its workforce as it explores strategic alternatives, its third round of layoffs in less than a year. \n\n\n  The San...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2428420675","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2428420675","pubTimestamp":1713472620,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"DermTech said Thursday that it plans to cut more than half of its workforce as it explores strategic alternatives, its third round of layoffs in less than a year.The San Diego-based dermatology-treatment company said that it would cut about 100 employees, or about 56% of its workforce, as it looks to conserve cash.DermTech's board has engaged TD Cowen to explore strategic alternatives, including a possible sale or merger.The company said it expects to incur a restructuring charge of about $1.6 million in the second quarter connected to the layoffs.DermTech said it plans to continue laboratory operations during the strategic review, believes it can still process orders of its melanoma test.The company said in late January that it would cut 15% of its headcount, or 30 employees, in a bid to prioritize revenue growth and cut expenses. Those reductions were on top of plans to cut 15% of its headcount in June as the company suspended all of its pipeline programs.DermTech suspended its pipel","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技"},"translate_title":"DermTech将削减56%的员工，探索各种选择","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DMTK":0.9},"content_text":"By Ben Glickman \n\n\n \n\n\n  DermTech said Thursday that it plans to cut more than half of its workforce as it explores strategic alternatives, its third round of layoffs in less than a year. \n\n\n  The San Diego-based dermatology-treatment company said that it would cut about 100 employees, or about 56% of its workforce, as it looks to conserve cash. \n\n\n  DermTech's board has engaged TD Cowen to explore strategic alternatives, including a possible sale or merger. \n\n\n  The company said it expects to incur a restructuring charge of about $1.6 million in the second quarter connected to the layoffs. \n\n\n  DermTech said it plans to continue laboratory operations during the strategic review, believes it can still process orders of its melanoma test. \n\n\n  The company said in late January that it would cut 15% of its headcount, or 30 employees, in a bid to prioritize revenue growth and cut expenses. Those reductions were on top of plans to cut 15% of its headcount in June as the company suspended all of its pipeline programs. \n\n\n  DermTech suspended its pipeline programs in June and looked to focus on growth potential for its melanoma test. \n\n\n \n\n\n  Write to Ben Glickman at ben.glickman@wsj.com \n\n\n  (END) Dow Jones Newswires\n\n\n  April 18, 2024 16:37 ET (20:37 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2428420675"}